Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianyi You

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|November 11, 2024
webTWAS 2.0: update platform for identifying complex disease susceptibility genes through transcriptome-wide association studyChen Cao, Mengting Shao, Jianhua Wang, et al.
Scientific Data|July 23, 2025
A highly annotated drug combination resource for catalyzing precision combinatorial therapyTianyi You, Lili Wang, Jianhua Wang, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal CancerJing Yang, Kai Song, Wenbing Guo, et al.
BMC Genomics|October 25, 2019
A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon CancerYelin Fu, Lishuang Qi, Wenbing Guo, et al.
Frontiers in Genetics|November 16, 2020
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon CancerTianyi You, Kai Song, Wenbing Guo, et al.
Briefings in Bioinformatics|March 3, 2020
An absolute human stemness index associated with oncogenic dedifferentiationHailong Zheng, Kai Song, Yelin Fu, et al.
Nucleic Acids Research|November 18, 2024
CAUSALdb2: an updated database for causal variants of complex traitsJianhua Wang, Liao Ouyang, Tianyi You, et al.
Cancer Gene Therapy|December 6, 2019
Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
Molecular Cancer|April 10, 2021
Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expressionHaihai Liang, Tong Yu, Yue Han, et al.
Molecular Cancer|August 13, 2018
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expressionHaihai Liang, Tong Yu, Yue Han, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|November 11, 2024
webTWAS 2.0: update platform for identifying complex disease susceptibility genes through transcriptome-wide association studyChen Cao, Mengting Shao, Jianhua Wang, et al.
Scientific Data|July 23, 2025
A highly annotated drug combination resource for catalyzing precision combinatorial therapyTianyi You, Lili Wang, Jianhua Wang, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal CancerJing Yang, Kai Song, Wenbing Guo, et al.
BMC Genomics|October 25, 2019
A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon CancerYelin Fu, Lishuang Qi, Wenbing Guo, et al.
Frontiers in Genetics|November 16, 2020
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon CancerTianyi You, Kai Song, Wenbing Guo, et al.
Briefings in Bioinformatics|March 3, 2020
An absolute human stemness index associated with oncogenic dedifferentiationHailong Zheng, Kai Song, Yelin Fu, et al.
Nucleic Acids Research|November 18, 2024
CAUSALdb2: an updated database for causal variants of complex traitsJianhua Wang, Liao Ouyang, Tianyi You, et al.
Cancer Gene Therapy|December 6, 2019
Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
Molecular Cancer|April 10, 2021
Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expressionHaihai Liang, Tong Yu, Yue Han, et al.
Molecular Cancer|August 13, 2018
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expressionHaihai Liang, Tong Yu, Yue Han, et al.
Pageof 2